The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice

[1]  V. Regitz-Zagrosek,et al.  Sex and gender differences in myocardial hypertrophy and heart failure , 2011, Wiener Medizinische Wochenschrift.

[2]  N. Karin.  The multiple faces of CXCL12 (SDF‐1α) in the regulation of immunity during health and disease , 2010, Journal of leukocyte biology.

[3]  H. White.  Editorial: why inhibition of lipoprotein-associated phospholipase A2 has the potential to improve patient outcomes , 2010, Current opinion in cardiology.

[4]  Daisuke Fujioka,et al.  A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis , 2010, EMBO molecular medicine.

[5]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[6]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[7]  S. Anker,et al.  Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. , 2009, Heart failure clinics.

[8]  A. Cederbaum.  Nrf2 and antioxidant defense against CYP2E1 toxicity , 2009, Expert opinion on drug metabolism & toxicology.

[9]  D. Waxman,et al.  Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes , 2009, Molecular Pharmacology.

[10]  K. Wasan,et al.  Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma , 2009, Lipids in Health and Disease.

[11]  S. Klein,et al.  Gonadectomy of male BALB/c mice increases Tim-3+ alternatively activated M2 macrophages, Tim-3+ T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis , 2009, Brain, Behavior, and Immunity.

[12]  C. Packard.  Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target , 2009, Current opinion in cardiology.

[13]  T. Elton,et al.  Cardiomyopathy: an overview. , 2009, American family physician.

[14]  Shyam Biswal,et al.  Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[15]  D. Gaudet,et al.  Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway , 2009, Clinical genetics.

[16]  N. Rose,et al.  Sex differences in autoimmune disease from a pathological perspective. , 2008, The American journal of pathology.

[17]  I. Quaye.  Haptoglobin, inflammation and disease. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  M. Kimura,et al.  Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. , 2008, The American journal of pathology.

[19]  A. El-Kadi,et al.  Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure. , 2008, Current drug metabolism.

[20]  Emily J. Greenspan,et al.  Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate , 2008, British Journal of Cancer.

[21]  V. Regitz-Zagrosek,et al.  Heart protein expression related to age and sex in mice and humans. , 2007, International journal of molecular medicine.

[22]  Roland Hetzer,et al.  Sexually dimorphic gene expression in the heart of mice and men , 2007, Journal of Molecular Medicine.

[23]  N. Rose,et al.  Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease1 , 2007, The Journal of Immunology.

[24]  P. Light,et al.  Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy , 2007, The Journal of physiology.

[25]  N. Rose,et al.  Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rβ1 signaling and IFN-γ increase inflammation in males independent from STAT4 , 2006, Brain Research.

[26]  R. Levy.  The role of cytosolic phospholipase A2-alfa in regulation of phagocytic functions. , 2006, Biochimica et biophysica acta.

[27]  M. Gavish,et al.  The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. , 2006, Pharmacology & therapeutics.

[28]  E. Silbergeld,et al.  Cutting Edge: T Cell Ig Mucin-3 Reduces Inflammatory Heart Disease by Increasing CTLA-4 during Innate Immunity1 , 2006, The Journal of Immunology.

[29]  A. Scott,et al.  Mycobacterium-Induced Potentiation of Type 1 Immune Responses and Protection against Malaria Are Host Specific , 2005, Infection and Immunity.

[30]  John Quackenbush,et al.  Multiple-laboratory comparison of microarray platforms , 2005, Nature Methods.

[31]  N. Rose,et al.  Mast Cells and Innate Cytokines are Associated with Susceptibility to Autoimmune Heart Disease Following Coxsackievirus B3 Infection , 2004, Autoimmunity.

[32]  N. Rose,et al.  IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication1 , 2003, The Journal of Immunology.

[33]  E. Lakatta,et al.  Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Thum,et al.  Testosterone, cytochrome P450, and cardiac hypertrophy , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  D. Kass,et al.  The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Jayavasu,et al.  Coxsackie B virus infection and myopericarditis in Thailand, 1987-1989. , 1998, The Southeast Asian journal of tropical medicine and public health.

[37]  J. McAnerney,et al.  Epidemic Coxsackie B virus infection in Johannesburg, South Africa , 1985, Journal of Hygiene.

[38]  D. Kass,et al.  The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design. , 2010, Journal of cardiac failure.

[39]  K. Rye,et al.  High-density lipoproteins, inflammation and oxidative stress. , 2009, Clinical science.

[40]  E. Dennis,et al.  Phospholipase A 2 structure/function, mechanism, and signaling 1 , 2009 .

[41]  N. Rose,et al.  Pathogenesis of myocarditis and dilated cardiomyopathy. , 2008, Advances in immunology.

[42]  N. Rose,et al.  Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. , 2007, Methods.

[43]  N. Rose,et al.  Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .

[44]  G. W. Dec,et al.  Introduction to Clinical Myocarditis , 2003 .

[45]  L. Cooper.  Myocarditis : from bench to bedside , 2003 .

[46]  P. Leedman,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Differential Posttranscriptional Regulation of Androgen Receptor Gene Expression by Androgen in Prostate and Breast Cancer Cells* , 2022 .